SCHEMBL2910704

SCHEMBL2910704

Cc1cccc(C(C)(C)C)c1Oc1ccccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 1/20 0.49
▸ GABRB2 P47870 1/20 0.49
▸ ALDH1A1 P00352 6/20 0.48
▸ TSHR P16473 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ ALOX15 P16050 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CA2 P00918 2/20 0.41
▸ TRPA1 O75762 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ GAA P10253 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ESR1 P03372 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3026757 0.87 GABRA1 (0.49) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL2913643 0.85 GABRA1 (0.59) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL11062493 0.83 TP53 (0.48) ALDH1A1TSHRALOX15LMNACA2
SCHEMBL2916470 0.81 ALDH1A1 (0.46) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL18997226 0.81 GABRA1 (0.47) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL11772725 0.80 GABRA1 (0.54) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL6061860 0.79 ALDH1A1 (0.59) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL25490589 0.76 GABRA1 (0.46) GABRA1GABRB2ALDH1A1TSHRTDP1
SCHEMBL11202500 0.75 MEN1 (0.47) ALDH1A1TSHRALOX15LMNACA2
SCHEMBL2952179 0.74 ALDH1A1 (0.38) GABRA1GABRB2ALDH1A1CA2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2110370-B1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2010-09-01 — — EP disclosed
EP-1348686-B1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2010-03-03 — — EP disclosed
EP-2110370-A1 Method of producing p-hydroxyphenylalkanols Sumitomo Chemical Company, Limited (JP) 2009-10-21 — — EP disclosed
CN-1307139-C Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2007-03-28 — — CN disclosed
US-6717020-B2 HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-06 — — US disclosed
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED 2003-10-16 — — US disclosed
CN-1448379-A Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2003-10-15 — — CN disclosed
EP-1348686-A1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols ADH1C, NR1H3, ADH5 GABRA1 4187/4885GABRB2 4176/4885ALDH1A1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback